Total Company Value: scilexholding.com (SCLX)
Scilex Holding Company (SCLX) is automating the production of therapeutic patches by implementing robotic dosing and packaging systems to reduce manual labor. This chart of the share price, which currently stands at 116.24, accompanies the company's strategy to replace opioids with safe migraine treatments. However, the business's success relies on patent extensions amid substantial debt and low operating margins.
Scilex Holding Company - analytical breakdowns and key metrics (SCLX)
- current quotes and average value forecast:
- company stock exchange capitalization indicators:
- business book valuation details:
- company total debt and liquidity indicators:
Debt to Capital Scilex Holding Company|SCLX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital scilexholding.com|SCLX - Company Debts|Debt to Net Assets Ratio Scilex Holding Company|SCLX - Company Long-Term Debt|Short-Term Debt Scilex Holding Company|Interim Coverage Ratio scilexholding.com
- earnings and valuation multiples indicators:
Analysis of all company metrics:Scilex Holding
Amid the adaptation of the debt structure and legal risks of Scilex Holding Company (SCLX), the calculated EV reflects the actual cost of business acquisition by summing market capitalization with the net debt burden. Analyzing this metric allows an investor to determine the real price of the asset, eliminating distortions caused by cash holdings, and to assess the risk of overpayment through the dynamics of the calculated EV.
Competitors of Scilex Holding Company (SCLX)
BIIB - Real Price to Acquire Entire Company|NBIX - Total Company Value|RGC: Total Company Value|AXSM (Axsome Therapeutics) - Real Price to Acquire Entire Company|Business Value ACAD|Total Company Value Xenon|Business Value VKTX (Viking Therapeutics Inc)|Enterprise Value SUPN|CPRX - Total Enterprise Value|Denali Therapeutics - Real Price to Acquire Entire Company|Enterprise Value harmonybiosciences.com HRMY|BHVN - Total Company Value|Value Adjusted for Debt and Cash AMLX (Amylyx Pharmaceuticals Inc)|Trevi Pharma (TRVI) - Total Company Value|Total Enterprise Value Praxis Corp (PRAX)|Total Company Value Anavex Life Sciences|ceribell.com (CBLL) - Company Buyout Price|Enterprise Value PRTA|Real Price to Acquire Entire Company alector.com ALEC|Enterprise Value ANNX (Annexon Inc.)|Company Buyout Price Omeros Corp (OMER)|NGNE - Total Company Value|ACIU: Total Company Value|VYGR: Enterprise Value|Total Enterprise Value Neumora (NMRA)|Real Price to Acquire Entire Company TVGN|Business Value ACOG (Alpha Cognition Corp)|Real Price to Acquire Entire Company CGTX (Cognition Therapeutics, Inc.)|IKT (inhibikase.com) - Value Adjusted for Debt and Cash|Enterprise Value SAVA (Cassava Sciences)|Value Adjusted for Debt and Cash ASRT|COYA - Total Company Value|Total Enterprise Value Vistagen Therapeutics|ovidrx.com (OVID) - Total Company Value|ABOS (acumenpharm.com) - Total Company Value|CRVO (CervoMed) - Enterprise Value|Business Value ATHE (Alterity Therapeutics Ltd)|Enterprise Value CLNN|Company Buyout Price pepgen.com|Total Company Value Jupiter Neurosciences JUNS|RLMD: Business Value|Annovis Bio - Enterprise Value|Full Takeover Company Value Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuroscience Inc) - Real Price to Acquire Entire Company|Klotho Neurosciences - Value Adjusted for Debt and Cash|NRSN (NeuroSense Therapeutics Ltd) - Enterprise Value|Real Price to Acquire Entire Company revivapharma.com (RVPH)|Total Company Value MetaVia Inc (MTVA)|NRXS - Total Enterprise Value|Total Company Value Helius Medical Technologies HSDT|PASG - Real Price to Acquire Entire Company|NEUP - Total Company Value|Full Business Value NERV|ATHA: Enterprise Value|Addex Therapeutics Ltd. (ADXN) - Enterprise Value|Total Company Value Alzamend Neuro Inc.|Business Value CYCN (Cyclerion)|Real Price to Acquire Entire Company PTIX (Protagenic Therapeutics)|KTTA - Total Enterprise Value|Total Company Value Cortigent CRGT|Company Buyout Price Avenue Therapeutics Inc. (ATXI)|Brainstorm Cell Therapeutics, Inc. - Enterprise Value|Cara Therapeutics Inc (CARA) - Real Price to Acquire Entire Company|Chromocell Therapeutics (CHRO) - Total Company Value|ELYM (Eliem Therapeutics Inc.) - Total Company Value|Real Price to Acquire Entire Company ITCI|Business Value LBPH (Longboard Pharmaceuticals Inc)|Total Company Value Marinus (MRNS)|NKGen Biotech Corp - Business Value|Enterprise Value NRBO (NeuroBo Pharmaceuticals)|sagerx.com (SAGE) - Total Enterprise Value|SNPX: Real Price to Acquire Entire Company|TRVN - Enterprise Value|vigilneuro.com (VIGL) - Total Company Value|anewmeds.com - Value Adjusted for Debt and Cash|Total Company Value Cerevel Therapeutics